The Institute of Cancer Research Selects the Labcyte Access™ Laboratory Workstation for Enhancing its Drug Discovery Capabilities
09:12 EDT 31 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Labcyte has announced that The Institute of Cancer Research (ICR) has
implemented its Access workstation to automate the production of
low-volume, assay-ready microplates from high-throughput screening and
fragment libraries for...
Other Sources for this Article
Labcyte Inc.
Pamela Lo
Toll-free: 877-742-6548
Tel:
408-747-2000 x211
Fax: 408-747-2010
pamela.lo@labcyte.com
www.labcyte.com
More From BioPortfolio on "The Institute of Cancer Research Selects the Labcyte Access™ Laboratory Workstation for Enhancing its Drug Discovery Capabilities"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
